Inspire Announces Results of Phase III Dry Eye Study | 合法藥品大搜索
2005年2月9日—InspirePharmaceuticalshasannouncedresultsofaPhaseIIIclinicalstudyofdiquafosoltetrasodiumfortreatmentofdryeye.
2005年2月9日 — Inspire Pharmaceuticals has announced results of a Phase III clinical study of diquafosol tetrasodium for treatment of dry eye.
Diquafosol phase 3 Diquafosol phase 3 汗癬圖 翰諾士股份有限公司 ciflogen抗生素 骨 復 舒 健保 得百利寧經痛 penicillin副作用 阿腸克錠副作用 日本 佐藤製藥 皮膚炎 消炎液
Efficacy and Safety of Topical 3% Diquafosol Ophthalmic ... | 合法藥品大搜索
由 K Nam 著作 · 2019 · 被引用 5 次 — Keywords: Dry eye diseaseEye dropsEfficacySafety3% diquafosol ... Ohashi Y; Diquafosol Ophthalmic Solution Phase 3 Study Group. Read More
Diquafosol Completed Phase 3 Trials for Dry Eyes | 合法藥品大搜索
clinicaltrials.gov Identifier, Title, Drugs. NCT01240382, Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye. Diquafosol ... Read More
Diquafosol Completed Phase 3 Trials for Dry Eye Syndrome ... | 合法藥品大搜索
Diquafosol Completed Phase 3 Trials for Dry Eye Syndrome (DES) Treatment ... NCT00403975, Study of Diquafosol Tetrasodium Ophthalmic Solution in ... Read More
Long | 合法藥品大搜索
由 Y Ohashi 著作 · 2020 · 被引用 3 次 — In a randomised, double-blind, phase III clinical trial conducted in 287 adult patients with DED over 4 weeks, diquafosol 3.0% ophthalmic ... Read More
Efficacy and safety of diquafosol ophthalmic solution in ... | 合法藥品大搜索
由 Y Matsumoto 著作 · 2012 · 被引用 96 次 — Both 1% and 3% diquafosol ophthalmic solutions are considered effective and ... solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Read More
A randomised, double | 合法藥品大搜索
由 E Takamura 著作 · 2012 · 被引用 118 次 — Diquafosol (3%) and sodium hyaluronate (0.1%) exhibit similar efficacy in improving ... Diquafosol Ophthalmic Solution Phase 3 Study Group:. Read More
Double-masked | 合法藥品大搜索
由 J Tauber 著作 · 2004 · 被引用 183 次 — Diquafosol tetrasodium was well tolerated and was superior to placebo ... Diquafosol has a favorable risk/benefit profile in a broad spectrum of patients with dry ... Phase III; Multicenter Study; Randomized Controlle Read More
Inspire Announces Results of Phase III Dry Eye Study | 合法藥品大搜索
2005年2月9日 — Inspire Pharmaceuticals has announced results of a Phase III clinical study of diquafosol tetrasodium for treatment of dry eye. Read More
相關資訊整理
【滴舒適點眼液】治療乾性角結膜炎病人之角膜以及結膜上皮損傷
藥品名稱:滴舒適點眼液許可證字號:衛部藥輸字第027852號許可證種類:製 劑適應症:治療乾性角結膜炎病人之角膜以及結膜上皮損...